Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17742
Country/Region: Nigeria
Year: 2016
Main Partner: Friends for Global Health Initiative in Nigeria
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,523,622 Additional Pipeline Funding: $1,028,019

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $461,508
Care: Orphans and Vulnerable Children (HKID) $289,090
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $107,669
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $268
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $140,447
Treatment: Adult Treatment (HTXS) $492,084
Treatment: Pediatric Treatment (PDTX) $32,556
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 10-14 Female 2017 5
GEND_GBV Age/Sex: 10-14 Male 2017 6
GEND_GBV Age/Sex: 20-24 Female 2017 1
GEND_GBV Age/Sex: 25-49 Female 2017 133
GEND_GBV Age/Sex: 25-49 Male 2017 55
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 229
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 45
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 155
GEND_GBV Number of people receiving post-GBV care 2017 200
GEND_GBV Sum of Age/Sex Disaggregates 2017 11
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,567
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,158
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 94,160
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 40,807
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 141,692
HTS_TST Service Delivery Point (Facility): Index testing 2017 197
HTS_TST Service Delivery Point (Facility): Inpatient 2017 206
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 104
HTS_TST Service Delivery Point (Facility): Other PITC 2017 6
HTS_TST Service Delivery Point (Facility): Outpatient 2017 61,050
HTS_TST Service Delivery Point (Facility): Pediatric 2017 6,681
HTS_TST Service Delivery Point (Facility): PMTCT 2017 48,153
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,501
HTS_TST Service Delivery Point (Facility): VCT 2017 22,794
HTS_TST Sum of Aggregated Age/Sex <15 2017 6,725
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 134,967
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 141,692
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 130
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 100
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,288
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,124
LAB_PT CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 12
LAB_PT CD4: Number of laboratories that participate in this PT program 2017 13
LAB_PT CD4: Number of laboratories that perform this testing 2017 13
LAB_PT Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT Early infant diagnostics: Number of laboratories that participate in this PT program 2017 1
LAB_PT Early infant diagnostics: Number of laboratories that perform this testing 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 12
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 13
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 13
LAB_PT HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT HIV viral load: Number of laboratories that participate in this PT program 2017 1
LAB_PT HIV viral load: Number of laboratories that perform this testing 2017 1
OVC_SERV Age/Sex: 18+ Female 2017 366
OVC_SERV Age/Sex: 18+ Male 2017 366
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 3,299
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 3,298
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 7,329
OVC_SERV Sum of Age/Sex disaggregates 2017 732
PMTCT_ART Already on ART at beginning of current pregnancy 2017 222
PMTCT_ART New on ART 2017 197
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 48,143
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 204
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 215
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 2
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 419
PMTCT_STAT By: Known positives at entry 2017 246
PMTCT_STAT By: Number of new positives identified 2017 196
PMTCT_STAT Number of new ANC and L&D clients 2017 50,680
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 48,143
PMTCT_STAT Sum of Positives Status disaggregates 2017 442
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 74
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 71
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 163
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 150
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 467
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 421
TB_SCREENDX Screen Result: Screened Positive for TB 2017 522
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 15,764
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 6,009
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 285
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 586
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 22,644
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 19
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 445
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 16
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 376
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 856
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 951
TX_CURR Aggregated Age/Sex: <15 Female 2017 451
TX_CURR Aggregated Age/Sex: <15 Male 2017 432
TX_CURR Aggregated Age/Sex: 15+ Female 2017 11,221
TX_CURR Aggregated Age/Sex: 15+ Male 2017 5,398
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 17,502
TX_CURR Sum of Aggregated Age/Sex <15 2017 883
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 16,619
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 17,502
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 51
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 41
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,287
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,145
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,524
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,524
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 17,502
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 15,752
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 518
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 442
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 9,991
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 4,801
TX_PVLS Numerator: Indication: Routine 2017 12,600
TX_PVLS Numerator: Indication: Targeted 2017 3,152
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 575
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 494
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 11,098
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 5,335
TX_PVLS_den Denominator: Indication: Routine 2017 14,002
TX_PVLS_den Denominator: Indication: Targeted 2017 3,500
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 70
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 65
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,476
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 730
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,341
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,753
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 84
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 78
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,735
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 856
Cross Cutting Budget Categories and Known Amounts Total: $83,091
Human Resources for Health $17,725
Gender: Gender Equality $6,375
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Based Violence (GBV) $58,991
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation